Published online May 19, 2025. doi: 10.5498/wjp.v15.i5.100731
Revised: December 16, 2024
Accepted: March 7, 2025
Published online: May 19, 2025
Processing time: 244 Days and 8 Hours
Speech and language therapy (ST) might moderate the prognosis in children with attention deficit and hyperactivity disorder (ADHD) comorbid with speech delay. This study investigated whether ST in children with ADHD is associated with a decreased risk of subsequent psychiatric disorders.
To investigate whether ST in children with ADHD is associated with a decreased risk of subsequent psychiatric disorders.
The population-based National Health Insurance Research Database in Taiwan was used. Hazards of subsequent psychiatric disorders were compared between those who received ST and a propensity-score matched comparison group by Cox regression analyses.
Of 11987 children with ADHD identified from the dataset, 2911 (24%) had received ST. The adjusted hazard ratio for any subsequent recorded psychiatric disorder was 0.72 (95% confidence interval: 0.63-0.82) in children who received ST compared to the matched counterparts. This protective association was only statistically significant in the subgroup that received both medication and behavioral interventions.
ST can moderate the effects of integrated early interventions in ADHD children with speech delay.
Core Tip: Speech therapy can moderate the treatment effect for attention deficit and hyperactivity disorder (ADHD) children with speech delay problem. Speech therapy in children with ADHD is associated with a decreased risk of subsequent psychiatric disorders. Multi-modal managements including medication and behavioral intervention may help strengthen the protective effect in addition to getting speech therapy.